Sorted By:


PhRMA Statement on Need to Modernize FDA Regulations Governing Information-Sharing about Medicines

PhRMA  |  Press Release

“As outlined in PhRMA’s recently announced Principles on Responsible Sharing of Truthful and Non-Misleading Information, greater sharing of information between biopharmaceutical companies, payers and health care professionals can benefit patient care and insurance coverage by ensuring more patients receive the best treatment for them.”

The importance of the Bayh-Dole Act

PhRMA  |  Blog Post

Today, the law’s technology transfer policy is fundamental to the current, highly successful U.S. biomedical R&D ecosystem and has helped foster the development of innovative therapies that have revolutionized medicine and patients’ lives in cancer and many other disease areas.

Clinical Trials

PhRMA  |  From PhRMA

The panel will then advise the agency on whether to approve the application and under what conditions.

Dr. William "Bill" Chin, M.D.

PhRMA  |  Biography

His impressive career is exemplified in part by his extensive bibliography of nearly 300 papers, chapters and books, most of which were generated during his 25 years on the Harvard Medical School faculty.

PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check

PhRMA  |  Blog Post

Innovation Spotlight: What is the Future of Health Care?

PhRMA  |  Video

The speakers also touched upon policy solutions to advance market-based reforms that promote competition and modernize the drug discovery and development process.

Week in Review: Keeping Patients In-The-Know

PhRMA  |  Blog Post

We will continue to post resources and helpful information to our website and on social media in honor of Rare Disease Week and Rare Disease Day, and will be highlighting the various tweetchats that occurred in our latest Conversations forum later this week.

Print Ad: Hospital Markups

PhRMA  |  Graphic

These hospital markups lead to higher costs for everyone - patients, employers and payers.

Fact Check Friday: The truth about drug importation and patient safety

PhRMA  |  Blog Post

The Secretary has had this power since the early 2000s, and yet, not a single Secretary, either Democratic or Republican, has been able to make that certification.

A new era in cancer

PhRMA  |  Blog Post

Elizabeth Jaffee of Johns Hopkins, Sean Parker of the Parker Institute for Cancer Immunotherapy and Mark Alles, chief executive officer at Celgene.

Intellectual Property

PhRMA  |  From PhRMA

In addition, PhRMA supports IP Progress - Discovery the Power of Invention.

Medicare Monday: Managing Diabetes Thanks to Medicare Part D

PhRMA  |  Graphic


Amy Miller

PhRMA  |  Biography

A former AAAS fellow, she also served as a domestic policy advisor to Senator Jay Rockefeller.

Strengthening IP would significantly boost India’s economy

PhRMA  |  Blog Post

Among Indian transportation companies, scientific instrument firms, pharmaceuticals and biotechnology companies, increases in R&D intensity would elevate value-added per employee – consequently, wage rates would rise.

Inside The Race To Diagnose Cancer From A Simple Blood Draw

From Hope To Cures  |  From Our Network

Unless the flight attendants get in the way, Haber added pointedly.

340B Spotlight: New analysis finds 340B program growth continues to accelerate despite false claims

PhRMA  |  Blog Post

The paper shows that the program has been growing faster than overall outpatient pharmaceutical sales since 2010—raising questions about the sustainability of the program.

PhRMA Statement on FDA Communications Hearing

PhRMA  |  Press Release

To learn more about PhRMA’s Principles, click here.

Past free trade agreements provide valuable lessons for future success

PhRMA  |  Blog Post

President Obama’s 2016 trade agenda will be the centerpiece of a hearing later this month, as well as a prime opportunity to bring up the lack of past trade agreement implementation.

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George Scangos Assume New Posts

PhRMA  |  Press Release

Success will require not only superior science but also sound public policy.

Director - Communications

PhRMA  |  PhRMA Career

We are committed to supporting our family of professionals at PhRMA and strive to create programs that help our team members manage the challenges of balancing a fast-paced career with their own personal goals.

Chart Pack: Cancer Medicines Value in Context

PhRMA  |  Report

Data and information found in this publication were drawn from a wide range of sources, including government agency reports, peer-reviewed journals, and the Pharmaceutical Research and Manufacturers of America’s (PhRMA’s) own research and analysis.

NORD on the Need for More Collaboration to Drive Progress for Rare Disease Patients

PhRMA  |  Blog Post

------------------------------------- Peter L.

Week in Review: The latest from PhRMA

PhRMA  |  Blog Post

A new paper from the Duke-Margolis Center for Health Policy rightly makes the argument in favor of establishing a more effective regulatory framework for communications between biopharmaceutical companies and health care professionals.

PhRMA Applauds 2016 We Work For Health Champion Award Winners

PhRMA  |  Press Release

Aaron Graham, executive director, brand safety & security, Boehringer Ingelheim Adam Taliaferro, associate director, state strategy & policy, Bristol-Myers Squibb Michele Schmidt, R.N., executive director, global project leadership, Celgene Pauline Coderre, R.Ph., M.S., CCP, health education consultant, Eli Lilly and Company Christine Schnackenberg, Ph.D., FAHA, senior scientific investigator, GlaxoSmithKline Norris Turner Jr., Pharm.D., Ph.D., therapeutic area director, healthcare quality systems, strategic customer group, Janssen Pharmaceutical Companies of Johnson & Johnson Marilyn Mainardi, associate director, market access, USP pricing and reimbursement, Merck Nancy Bell, Pharm.D., medical outcomes specialist, Pfizer Jayaram Srirangam, Ph.D., MBA, associate research fellow in worldwide PharmSci, Pfizer Diana Lenkowsky, vice president, facilities and administrative services, Purdue Pharma Alok Goel, senior manager, HR operations & special projects, Sanofi US To learn more about this year’s distinguished honorees, visit We Work for Health’s website at

How patients with hypertension save with Medicare Part D

PhRMA  |  Graphic


You have reviewed the first 250 results out of 1100. Each page contains 25 results. You're on page 10.

prev 7 8 9 10 11 12 next